Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization Microbial Immunity and Vaccines

Streptococcus pneumoniae commonly inhabits the nasopharynx as a member of the commensal biofilm. Infection with respiratory viruses, such as influenza A virus, induces commensal S. pneumoniae to disseminate beyond the nasopharynx and to elicit severe infections of the middle ears, lungs, and blood that are associated with high rates of morbidity and mortality. Current preventive strategies, including the polysaccharide conjugate vaccines, aim to eliminate asymptomatic carriage with vaccine-type pneumococci. However, this has resulted in serotype replacement with, so far, less fit pneumococcal strains, which has changed the nasopharyngeal flora, opening the niche for entry of other virulent pathogens (e.g., Streptococcus pyogenes, Staphylococcus aureus, and potentially Haemophilus influenzae). The long-term effects of these changes are unknown. Here, we present an attractive, alternative preventive approach where we subvert virus-induced pneumococcal disease without interfering with commensal colonization, thus specifically targeting disease-causing organisms. In that regard, pneumococcal surface protein A (PspA), a major surface protein of pneumococci, is a promising vaccine target. Intradermal (i.d.) immunization of mice with recombinant PspA in combination with LT-IIb(T13I), a novel i.d. adjuvant of the type II heat-labile enterotoxin family, elicited strong systemic PspA-specific IgG responses without inducing mucosal anti-PspA IgA responses. This response protected mice f...
Source: Infection and Immunity - Category: Infectious Diseases Authors: Tags: Microbial Immunity and Vaccines Source Type: research

Related Links:

Number of cases worldwide passes 30 million; Victoria announces 21 new Covid-19 cases and seven more deaths; UK faces possible second national lockdown. Follow all the developmentsMutant virus: should we be worried that Sars-CoV-2 is changing ?UK entering second wave of virus, Johnson warns‘Shocking’: Trump under fire from ex-adviser for Covid failures5.31amBSTThe Victorian Department of Health and Human Services has put out some more information on the latest case numbers today.The 21 cases is the lowest number of new cases since 24 June.Of the 834 current active cases in Victoria:5.12amBSTThe Australian minis...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Infectious diseases Science World news Source Type: news
Contributor : Natalia V KirienkoSeries Type : Expression profiling by arrayOrganism : Caenorhabditis elegansTraditional treatments for bacterial infection have focused upon directly inhibiting growth of the pathogen. However, an equally important determinant of infection outcome is the host defense response. We previously performed a high-throughput chemical screen to identify small molecules that rescued the nematode Caenorhabditis elegans from infection by Pseudomonas aeruginosa. Over 20 of the hits stimulated host defense gene expression. During in-depth studies of five such molecules using microarray analysis, bioinfor...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by array Caenorhabditis elegans Source Type: research
US president’s prediction comes as CDC reverses course on testing guidelines
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
President Trump acknowledged that an authorized vaccine for ‘every American’ may not be distributed until next year. An Iranian official says the country has become a “red zone” as cases and deaths surge.
Source: NYT Health - Category: Consumer Health News Tags: Coronavirus (2019-nCoV) Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
The viruses' symptoms are similar, making it hard to distinguish between them. Doctors are urging people to get the annual flu vaccine to prevent a "twindemic" this fall and winter.
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Source Type: news
Companies are struggling to recruit diverse volunteers in final U.S. tests of possible COVID-19 vaccines
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
The 389-person clinical trial, which used the rheumatoid arthritis drug Actemra in patients with Covid-associated pneumonia, is part of a "call to action" for more-inclusive drug studies.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Publication date: Available online 18 September 2020Source: Progress in Natural Science: Materials InternationalAuthor(s): Zonghua Liu, Linghong Huang, Wei Xue
Source: Progress in Natural Science: Materials International - Category: Materials Science Source Type: research
Abstract Viral infections may predispose the airways to secondary bacterial infections that can lead to unfavorable progression of principally self-limiting illnesses. Such complicated respiratory infections include pneumonia, bronchitis, sinusitis, acute otitis media, and sepsis, which cause high morbidity and lethality. Some of the pathogenic consequences of viral infections, like the expression of bacterial adhesion receptors and the disturbance of physical barrier integrity due to inflammation, may create permissive conditions for co-infections. Influenza virus A (H3N2) is a major pathogen that causes secondar...
Source: Virus Research - Category: Virology Authors: Tags: Virus Res Source Type: research
More News: Haemophilus Influenzae (Hib) | Infectious Diseases | Influenza | Influenza Vaccine | Meningitis Vaccine | Otitis | Otitis Media | Pneomococcal Vaccine | Pneumonia | Respiratory Medicine | Staphylococcus Aureus | Vaccines